{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:14:56Z","timestamp":1789877696059,"version":"4.0.1"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/mop.0b013e32834c9251","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:52:52Z","timestamp":1317757972000},"page":"633-639","source":"Crossref","is-referenced-by-count":24,"title":["Translational research"],"prefix":"10.1097","volume":"23","author":[{"given":"Omar S.","family":"Khwaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"R2-12-20210206","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature.","volume":"68","author":"Neul","year":"2010","journal-title":"Ann Neurol"},{"key":"R4-12-20210206","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.22154","article-title":"Rett syndrome diagnostic criteria: lessons from the Natural History Study.","volume":"68","author":"Percy","year":"2010","journal-title":"Ann Neurol"},{"key":"R5-12-20210206","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/08830738050200082401","article-title":"Neuropathology of Rett syndrome.","volume":"20","author":"Armstrong","year":"2005","journal-title":"J Child Neurol"},{"issue":"Suppl 1","key":"R6-12-20210206","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0387-7604(01)00333-3","article-title":"The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.","volume":"23","author":"Nan","year":"2001","journal-title":"Brain Dev"},{"key":"R7-12-20210206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/epi.09.13","article-title":"Evolving role of MeCP2 in Rett syndrome and autism.","volume":"1","author":"Lasalle","year":"2009","journal-title":"Epigenomics"},{"key":"R9-12-20210206","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1206593","article-title":"Adult neural function requires MeCP2.","volume":"333","author":"McGraw","year":"2011","journal-title":"Science"},{"key":"R10-12-20210206","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription.","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"R11-12-20210206","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.","volume":"37","author":"Skene","year":"2010","journal-title":"Mol Cell"},{"key":"R12-12-20210206","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","article-title":"Brain-specific phosphorylation of MeCP2 regulates activity-dependent BDNF transcription, dendritic growth, and spine maturation.","volume":"52","author":"Zhou","year":"2006","journal-title":"Neuron"},{"key":"R13-12-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/ebm.2010.010261","article-title":"Experimental models of Rett syndrome based on Mecp2 dysfunction.","volume":"236","author":"Calfa","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"R14-12-20210206","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopsych.2008.10.036","article-title":"Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.","volume":"65","author":"Monteggia","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R15-12-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuron.2011.03.001","article-title":"Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice.","volume":"70","author":"Noutel","year":"2011","journal-title":"Neuron"},{"key":"R16-12-20210206","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"R17-12-20210206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature10214","article-title":"A role for glia in the progression of Rett syndrome.","volume":"475","author":"Lioy","year":"2011","journal-title":"Nature"},{"key":"R18-12-20210206","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome.","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"R19-12-20210206","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","article-title":"The MECP2 duplication syndrome.","volume":"152A","author":"Ramocki","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R20-12-20210206","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model.","volume":"89","author":"Brendel","year":"2011","journal-title":"J Mol Med"},{"key":"R21-12-20210206","doi-asserted-by":"crossref","first-page":"e20733","DOI":"10.1371\/journal.pone.0020733","article-title":"Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations.","volume":"6","author":"Vecsler","year":"2011","journal-title":"PLoS One"},{"key":"R22-12-20210206","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"R23-12-20210206","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"R24-12-20210206","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice.","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-12-20210206","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis.","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"R26-12-20210206","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0883073807309788","article-title":"Characterization of autism in young children with tuberous sclerosis complex.","volume":"23","author":"Jeste","year":"2008","journal-title":"J Child Neurol"},{"key":"R27-12-20210206","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/08830738040190090401","article-title":"Brain abnormalities in tuberous sclerosis complex.","volume":"19","author":"DiMario","year":"2004","journal-title":"J Child Neurol"},{"key":"R29-12-20210206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and AktPKB.","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"R30-12-20210206","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"R31-12-20210206","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1101\/gad.912401","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1.","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"R32-12-20210206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism.","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"R33-12-20210206","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","article-title":"Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.","volume":"31","author":"Ruvinsky","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"R34-12-20210206","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1101\/gad.1685008","article-title":"Tuberous sclerosis complex proteins control axon formation.","volume":"22","author":"Choi","year":"2008","journal-title":"Genes Dev"},{"key":"R35-12-20210206","doi-asserted-by":"crossref","first-page":"33784","DOI":"10.1074\/jbc.M802431200","article-title":"Rheb and mTOR regulate neuronal polarity through Rap1B.","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"R36-12-20210206","doi-asserted-by":"crossref","first-page":"27734","DOI":"10.1074\/jbc.M109.008177","article-title":"Specification of neuronal polarity regulated by local translation of CRMP2 and Tau via the mTOR-p70S6K pathway.","volume":"284","author":"Morita","year":"2009","journal-title":"J Biol Chem"},{"key":"R37-12-20210206","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nn.2477","article-title":"Tsc2-Rheb signaling regulates EphA-mediated axon guidance.","volume":"13","author":"Nie","year":"2010","journal-title":"Nat Neurosci"},{"key":"R38-12-20210206","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival.","volume":"27","author":"Meikle","year":"2007","journal-title":"J Neurosci"},{"key":"R39-12-20210206","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways.","volume":"25","author":"Kumar","year":"2005","journal-title":"J Neurosci"},{"key":"R40-12-20210206","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1523\/JNEUROSCI.2270-05.2005","article-title":"Control of dendritic arborization by the phosphoinositide-3-kinase-Akt-mammalian target of rapamycin pathway.","volume":"25","author":"Jaworski","year":"2005","journal-title":"J Neurosci"},{"key":"R41-12-20210206","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat Neurosci"},{"key":"R42-12-20210206","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"R43-12-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2006.03.011","article-title":"A role for the mTOR pathway in surface expression of AMPA receptors.","volume":"401","author":"Wang","year":"2006","journal-title":"Neurosci Lett"},{"key":"R44-12-20210206","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1523\/JNEUROSCI.1617-11.2011","article-title":"Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function.","volume":"31","author":"Bateup","year":"2011","journal-title":"J Neurosci"},{"key":"R45-12-20210206","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.21342","article-title":"Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.","volume":"63","author":"Talos","year":"2008","journal-title":"Ann Neurol"},{"key":"R46-12-20210206","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2 mouse model of tuberous sclerosis.","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"key":"R47-12-20210206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1 mice in the absence of cerebral lesions and seizures.","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann Neurol"},{"key":"R48-12-20210206","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.1005620107","article-title":"Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism.","volume":"107","author":"Young","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R49-12-20210206","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","article-title":"3rd, Mietzsch U, et al. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.","volume":"18","author":"Way","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R50-12-20210206","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI44909","article-title":"Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.","volume":"121","author":"Feliciano","year":"2011","journal-title":"J Clin Invest"},{"key":"R51-12-20210206","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann Neurol"},{"key":"R52-12-20210206","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"R53-12-20210206","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.","volume":"54","author":"Wong","year":"2003","journal-title":"Ann Neurol"},{"key":"R54-12-20210206","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.nbd.2009.12.020","article-title":"Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of tuberous sclerosis complex.","volume":"37","author":"Zeng","year":"2010","journal-title":"Neurobiol Dis"},{"key":"R55-12-20210206","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gad.16750211","article-title":"Tsc1 mutant neural stemprogenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle.","volume":"25","author":"Zhou","year":"2011","journal-title":"Genes Dev"},{"key":"R56-12-20210206","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"R57-12-20210206","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0234-09.2009","article-title":"Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation.","volume":"29","author":"Tyler","year":"2009","journal-title":"J Neurosci"},{"key":"R58-12-20210206","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1523\/JNEUROSCI.0232-09.2009","article-title":"Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.","volume":"29","author":"Narayanan","year":"2009","journal-title":"J Neurosci"},{"key":"R59-12-20210206","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.22090","article-title":"Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.","volume":"68","author":"Harrington","year":"2010","journal-title":"Ann Neurol"},{"key":"R60-12-20210206","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S0033291701004561","article-title":"Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis.","volume":"31","author":"Ridler","year":"2001","journal-title":"Psychol Med"},{"key":"R61-12-20210206","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00247-005-1539-y","article-title":"Magnetization transfer ratio measurements of the brain in children with tuberous sclerosis complex.","volume":"35","author":"Zikou","year":"2005","journal-title":"Pediatr Radiol"},{"key":"R62-12-20210206","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3174\/ajnr.A0642","article-title":"Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex.","volume":"28","author":"Makki","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"R63-12-20210206","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intell.2008.06.001","article-title":"Occult white matter damage contributes to intellectual disability in tuberous sclerosis complex.","volume":"37","author":"Yu","year":"2009","journal-title":"Intelligence"},{"key":"R64-12-20210206","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejrad.2008.04.017","article-title":"Cerebral diffusion tensor imaging in tuberous sclerosis.","volume":"71","author":"Piao","year":"2009","journal-title":"Eur J Radiol"},{"key":"R65-12-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2009.08.001","article-title":"Diffusion features of white matter in tuberous sclerosis with tractography.","volume":"42","author":"Krishnan","year":"2010","journal-title":"Pediatr Neurol"},{"key":"R66-12-20210206","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4161\/epi.5.7.13055","article-title":"Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.","volume":"5","author":"Urdinguio","year":"2010","journal-title":"Epigenetics"},{"key":"R67-12-20210206","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ijc.25126","article-title":"miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.","volume":"127","author":"Wada","year":"2010","journal-title":"Int J Cancer"},{"key":"R68-12-20210206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells.","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"R69-12-20210206","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1073\/pnas.1018979108","article-title":"Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome.","volume":"108","author":"Kim","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32834c9251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:49Z","timestamp":1786048129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-201112000-00012"}},"subtitle":["Rett syndrome and tuberous sclerosis complex"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32834c9251","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}